open access

Vol 79, No 1 (2011)
REVIEWS
Published online: 2010-12-28
Submitted: 2013-02-22
Get Citation

Leczenie przewlekłej obturacyjnej choroby płuc - bronchodylatacja i przeciwzapalna farmakoterapia celowana

Robert M. Mróz, Tomasz Skopiński, Adam Hołownia, Elżbieta Chyczewska, Jan J. Braszko
Pneumonol Alergol Pol 2011;79(1):32-38.

open access

Vol 79, No 1 (2011)
REVIEWS
Published online: 2010-12-28
Submitted: 2013-02-22

Abstract

Currently available pharmacological treatment of COPD relies mostly on prophylaxis (smoking cessation) and symptomatic treatment, i.e. inhaled anticholinergic agents, β2-agonists and phosphodiesterase inhibitors, aiming in their bronchodilatation capacity. Inhaled corticosteroid therapy is mainly prescribed in far advanced stages of the disease and its role in disease modification is still controversial. The authors analize currently available treatment modalities with regards to their potential anti-inflammatory and pleiotropic mode of action, which may lead to disease course modification.
Pneumonol. Alergol. Pol. 2011; 79, 1: 32-38

Abstract

Currently available pharmacological treatment of COPD relies mostly on prophylaxis (smoking cessation) and symptomatic treatment, i.e. inhaled anticholinergic agents, β2-agonists and phosphodiesterase inhibitors, aiming in their bronchodilatation capacity. Inhaled corticosteroid therapy is mainly prescribed in far advanced stages of the disease and its role in disease modification is still controversial. The authors analize currently available treatment modalities with regards to their potential anti-inflammatory and pleiotropic mode of action, which may lead to disease course modification.
Pneumonol. Alergol. Pol. 2011; 79, 1: 32-38
Get Citation

Keywords

COPD; anticholinergic agents; corticosteroids

About this article
Title

Leczenie przewlekłej obturacyjnej choroby płuc - bronchodylatacja i przeciwzapalna farmakoterapia celowana

Journal

Advances in Respiratory Medicine

Issue

Vol 79, No 1 (2011)

Pages

32-38

Published online

2010-12-28

Bibliographic record

Pneumonol Alergol Pol 2011;79(1):32-38.

Keywords

COPD
anticholinergic agents
corticosteroids

Authors

Robert M. Mróz
Tomasz Skopiński
Adam Hołownia
Elżbieta Chyczewska
Jan J. Braszko

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl